Japanese Ambassador to India Inaugurates Japan-India Institute for Manufacturing (JIM), at a Pharma company premises in Gujarat

Ahmedabad: Japanese Ambassador to India Satoshi Suzuki today inaugurated Japan-India Institute for Manufacturing (JIM), at the Indian premises of a Japanese pharma company in Ahmedabad of Gujarat.

The JIM was inaugurated in the premises of Otsuka Pharmaceutical India Private Limited here. Suzuki was welcomed by the CEO of the pharma company, Motoyuki Sakiyama.

Notably, JIM is born out of a collaboration between the Governments of Japan and India to create a pool of skilled manpower for manufacturing in India. It follows from a Memorandum of Cooperation (MoC) signed between Ministry of Economy, Trade and Industry (METI), Government of Japan and Ministry of Skill Development and Entrepreneurship (MSDE), Government of India, for a “Manufacturing Skill Transfer Promotion Programme” to train youths in India over.

Additionally, Otsuka-JIM offers a course on Japanese Manufacturing Practices and Processes to its students. The curriculum of the Japanese Manufacturing Practices and Processes course is developed by AOTS, Japan under guidance of Ministry of Economy,Trade and Industry (METI), Japan. This specially designed training module covers important Japanese soft-skills like Kaizen, 5S, and 3G. Government of Japan approved course for skills in Japanese Manufacturing Practices and Processes, is one of the unique aspects of JIM. This course will create a pool of skilled manpower for manufacturing in India.

Stating the importance of creating skilled manpower and how it is important for growth of the country, Sakiyama on the occasion said that this initiative taken by the Governments of India and Japan was going to benefit India in a long run. By imparting skill education to the youth, we were going to fulfill the dream of Prime Minister Narendra Modi and this country, of Make inIndia and Skill India”.

Otsuka Pharmaceutical India Pvt Ltd (OPI) is a subsidiary of Otsuka Pharmaceutical Factory and deals in Infusion Business in India and other emerging markets.


error: Content is protected !!